Effect of Maternal Awareness of the Duration fo the Second Stage of Labor on the Length of the Second Stage

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorValmiki Vijay Seeraj

About this trial

This study aims to understand whether informing laboring patients about how long they have been pushing during the second stage of labor affects the length of that stage and the overall childbirth experience.

The second stage of labor is the period from when the cervix is fully dilated until the baby is delivered. When this stage lasts longer than expected, it can increase the chance of complications such as assisted delivery with vacuum or forceps, cesarean delivery, heavy bleeding after delivery, and certain neonatal complications. Although healthcare providers routinely track the duration of the second stage, patients are not always told how long they have been pushing. Some providers believe that sharing this information may help motivate patients and improve their sense of control, while others worry that it could increase stress or pressure.

In this study, participants will be randomly assigned to one of two groups. In the intervention group, patients will receive regular updates about how long they have been pushing during the second stage of labor, and a visible timer will be used. In the comparison group, patients will receive standard care, which does not include structured time updates.

All participants will receive the same medical care otherwise. The study will measure the length of the second stage of labor as well as maternal and neonatal outcomes such as the type of delivery, postpartum complications, newborn health indicators, and admission to the neonatal intensive care unit. Participants will also be asked to complete a short questionnaire after delivery about their childbirth experience and sense of control during labor.

The risks of this study are minimal because the intervention involves only providing information about time during labor. There are no changes to medical treatment or standard care. The information gained from this research may help clinicians improve communication with patients during labor and may identify simple ways to enhance patient experience and potentially improve labor outcomes.

Participation in the study is voluntary, and patients may decline or withdraw at any time without affecting the care they receive.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Singleton, cephalic presentation

Gestational age ≥ 37+0 weeks at delivery.

Reached the second stage of labor (complete cervical dilation with intention to proceed with vaginal delivery).

Ability to understand study information and provide informed consent.

Disqualifiers

Planned cesarean delivery.

Intrauterine fetal demise.

Critical maternal illness requiring intensive hemodynamic or respiratory support.

Cognitive impairment or language barrier precluding consent and comprehension of instructions.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Time aware

    Behavioral

    Participants randomized to the intervention arm will receive structured awareness of the duration of the second stage of labor. At complete cervical dilation, a nurse or provider will initiate an electronic timer and inform the participant that elapsed pushing time will be monitored and communicated throughout the second stage. The timer will be visible to the participant. Standardized verbal updates on elapsed time will be provided every 30 minutes, with additional reminders at clinically relevant thresholds based on parity and neuraxial analgesia status. Feedback will be supportive, non-coercive, and focused on encouragement and shared decision-making. The intervention is intended to increase maternal awareness of labor progress without changing clinical management. All other aspects of care, including labor positioning, coaching, analgesia, fetal monitoring, and decisions regarding operative vaginal delivery or cesarean delivery, will follow standard institutional protocols.

Treatment groups

240 Participants
are divided into 2 treatment groups
Group A: Time awarenessExperimental treatment 1 intervention
Group B: Usual careNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Mean difference of the duration of the second stage of labor

The duration of the second stage will be recorded from the time of full cervical dilation to the expulsion of the neonate.

Time frame
From complete cervical dilation(10cm-which is the start of the second stage) to delivery of the neonate(either spontaneously or operative vaginal delivery), or cessation of pushing for cesarean delivery, maximum of 4 hours from complete cervical dilation
2

Duration of the second stage of labor

How long it took from full cervical dilatation to delivery of the fetus

Time frame
full cervical dilatation to expulsion of the fetus

Secondary outcomes

1

Maternal satisfaction and perceived control

The Labor agentry scale scored from 10-70. Higher scores indicate greater sense of autonomy, empowerment, and active involvement during labor. Lower scores indicate helplessness, a loss of control, or feeling overwhelmed by the birthing process.

Time frame
Within 48 hours postpartum
2

Maternal self-report exhaustion

A likert scale to assess maternal exhaustion

Time frame
within 24 hours postpartum
3

Degree of perineal laceration.

First-degree tear: superficial skin or vaginal mucosal laceration Second-degree tear: laceration extends through underlying perineal muscles but no sphincter involvement. Third-degree tear: laceration extends to external and or internal anal spincters but not the rectal mucosa. Fourth-degree tear: Laceration involves the rectal mucosa

Time frame
Within 10-minutes from the delivery of the placenta
4

5-minute APGAR score

The Apgar score compreises of 5 components, weighed evenly and assigned 0,1,or 2. The components are summed at 5 minutes after delivery of the neonate. Activity(0= absent; 1= some tone and flexed limbs; 2= active), Pulse( 0= no pulse; 1= less than 10bpm; 2= greater than 100bpm), Grimace( 0= floppy; 1= minimal response; 2=prompt response), Appearance(0= blue or pale; 1= pink body, blue limbs; 2= pink body and limbs), Respiration( 0=absent breathing; 1= slow and irregular breathing; 2= vigorous cry) A score of \<7/10 is considered non-reassuring, while 7 or more is considered assuring neonatal status.

Time frame
5 minutes after delivery of neonate.

Other outcomes

1

Postpartum endometritis

Diagnosed by the presence of at least two (2) of the following: 1\. Fever (temperature greater than or equal 38 degrees celcius or 100.4 degree Fahrenheit; 2. Pain or uterine tenderness with no other recognized cause and 3. purulent drainge from the uterus.

Time frame
Time of delivery to discharge of mother( within 96 hours after delivery)

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Valmiki Vijay Seeraj

Lead sponsor

Bronxcare Hospital System

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: